Clinical trials
Leukemia, Myelogenous, Chronic, BCR-ABL Positive trials in India
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
18 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2006 | 2 |
| 2007 | 2 |
| 2008 | 2 |
| 2009 | 1 |
| 2011 | 1 |
| 2013 | 2 |
| 2014 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 12 |
| Active, not recruiting | 2 |
| Unknown status | 2 |
| Recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 5 |
| Pfizer | 3 |
| Teva Branded Pharmaceutical Products R&D, Inc. | 2 |
| Amneal Pharmaceuticals, LLC | 1 |
| Ascentage Pharma Group Inc. | 1 |
| Bristol-Myers Squibb | 1 |
| Command Hospital, India | 1 |
| Hoffmann-La Roche | 1 |
| Il-Yang Pharm. Co., Ltd. | 1 |
| Post Graduate Institute of Medical Education and Research, Chandigarh | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 18 |
| Philadelphia Chromosome | 5 |
| Leukemia | 4 |
| Bronchiolitis Obliterans Syndrome | 2 |
| Carcinoma, Renal Cell | 1 |
| Dwarfism | 1 |
| Gastrointestinal Stromal Tumors | 1 |
| Hematologic Diseases | 1 |
| Leukemia, Myeloid | 1 |
| Leukemia, Myeloid, Chronic-Phase | 1 |
Trials
Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.